PHARMA PATIENT ACCESS WORLD CONGRESS 2025 EUROPE
Improving Patient Access for Better Health Outcomes and Quality of Life
Copthorne Tara Hotel London Kensington, London, UK, London, United Kingdom
Day 1 - Wednesday 11th June 2025
- Auditorium 1
TRENDS & STRATEGIES IN PATIENT ACCESS
- Ensuring that patients can access products in a timely and affordable manner.
- Need to have access to data and insights early and often to make informed decisions about how pharma and biotech companies get their drugs to patients
- Digitizing healthcare to improve patient access
- Demonstrating cost-effectiveness of the product
- What is most important to patients?
Moderator:
Panelists:
- Addressing the shifting regulations
- Payer revenue optimization strategies
- The need for a 360-degree perspective across the drug development life cycle,
- The promise of real-world data (RWD) to address complex challenges
- How can we seize this opportunity to improve patient access to medicines?
- Assessing the impact of the regulation on national HTAs
- Strategic implications for health technology developers
- Its influence on price and reimbursement negotiations.
- Meeting growing demands for rigorous data requirements
- Understanding of increasingly diverse environment
- Strategic and adaptive approach in navigating complexities of different ecosystem
- Breaking down silo mentality
- Harmonizing access needs and aligning strategies at an early stage
- Advancing landscape and drivers in medical devices
- The importance of early and continuous stakeholder engagement
- How multi-stakeholder collaboration streamlines the path to market and guarantees that medical devices are thoroughly designed, tested, and deployed.
- Significance of patient-centered design on market access
- Prioritizing patient needs and preferences to enhance patient outcomes
- Adopting tech-powered tools that enables to have a more direct relationship with HCPs and the patients they serve
- Innovative technologies that make patient-focused approaches scalable and efficient
- Innovative steps to improve access strategy by interacting with PAGs
- Best practices while interacting with PAGs in order to guarantee efficient cooperation and patient needs alignment.
- Integrating patient insights to improve the acceptance and relevance of health innovations
- Overcoming challenges interacting with PAGs
REGULATORY & COMMERCIALISATION
- Key trends that will affect the European biopharmaceutical market access landscape
- Impact of both the EU’s industrial pharma policy and the health technology assessment (HTA) landscape
- Overcoming the increasing constraints on government healthcare budgets
- Fundamental policy changes affecting the industry
- Breaking down silos for comprehensive strategy to anticipate challenges and opportunities in both short and long term
- Addressing urgent policy changes and stakeholder concerns while planning for the future
- Integrating patient-centricity into the broader patient access strategy
- Harmonisation imperative for sustained growth
- Varying framework in place to improve patient access to innovative medicines
- Considerations for a suitable pharmaceutical regulatory and clinical framework
- How regulation can help to unlock the potential of innovative medicines
- Streamlined regulatory framework bringing breakthroughs to patients faster
- Improving provider schedules and allowing patients to schedule their own appointment to improve access and patient satisfaction.
- Using technology to improve care coordination
- Streamlining processes to reduce inefficiencies, delays and revenue loss
- Facilitating patient engagement with the use of patient portals, apps and educational resources
- Value-based approach to affordability
- Varying healthcare needs and affordability challenges
- Programmes that provide patients financial support to help fund therapy expenditures
- Significant pitfalls associated with programmes design
- Addressing the payer activation and reimbursement challenges
- The impact of regulatory roadblocks and competition
- Overcoming the issue on inadequate market adoption by HCPs
- Patient engagement and adoption challenges
- Encourage shared decision-making to help patients feel more empowered and make informed choices.
- Open and clear communication between patients and providers to build trust and understanding.
- Educate patients to ensure patients understand their treatment plan, medications, and diagnosis
- Use innovative technology to improve the patient experience
- Ensuring that patients have access to the right treatments at the right time and fair price that aligns with the effectiveness of a drug in treating disease
- Establishing pricing and reimbursement sustainability for both the pharmaceutical manufacturer and the healthcare payer
- Incorporating patient input to ensure that their drugs address the specific needs, preferences, and quality of life concerns of patients.
- Collaborative, patient-centric care approach that enhances the quality of life for patients with complex chronic conditions
- Removing barriers to treatment and improving patient access to essential therapies.